Citation 80080

RASOANAIVO,P: RATSIMAMANGA-URVERG,S: RAFATRO,H: RAMANITRAHASIMBOLA,D: PALAZZINO,G: GALEFFI,C: NICOLETTI,M:. (1998). ALKALOIDS OF HERNANDIA VOYRONII: CHLOROQUINE-POTENTIATING ACTIVITY AND STRUCTURE ELUCIDATION OF HERVELINE D.. 64(1)

Citation Details

TitleALKALOIDS OF HERNANDIA VOYRONII: CHLOROQUINE-POTENTIATING ACTIVITY AND STRUCTURE ELUCIDATION OF HERVELINE D.
AuthorsRASOANAIVO,P: RATSIMAMANGA-URVERG,S: RAFATRO,H: RAMANITRAHASIMBOLA,D: PALAZZINO,G: GALEFFI,C: NICOLETTI,M:
Year1998
Volume64
Issue1

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Hernandia voyronii (HERNANDIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
HERVELINE D
None
2
ANTIMALARIAL ACTIVITY
MEDICINAL FOLKLORE REPORTED FOR
NoneNone
3
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
HERVELINE D
WEAK ACTIVITY
4
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE D
ACTIVE
5
ANTIMALARIAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE D
ACTIVE
6Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HERVELINE A
None
7
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE A
ACTIVE
8
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE A
WEAK ACTIVITY
9
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VIVO
HERVELINE A
WEAK ACTIVITY
10Not specified
ISOLATION AND IDENTIFICATION OF
HERVELINE B
None
11
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE B
ACTIVE
12
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE B
WEAK ACTIVITY
13
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VIVO
HERVELINE B
WEAK ACTIVITY
14Not specified
ISOLATION AND IDENTIFICATION OF
HERVELINE C
None
15
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE C
ACTIVE
16
ANTIMALARIAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
HERVELINE C
ACTIVE
17
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
RETICULINE,(S):
WEAK ACTIVITY
18
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
RETICULINE,(S):
WEAK ACTIVITY
19Not specified
ISOLATION AND IDENTIFICATION OF
LAUDANOSINE
None
20
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
LAUDANOSINE
WEAK ACTIVITY
21
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LAUDANOSINE
WEAK ACTIVITY
22
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LAUDANOSINE
INACTIVE
23
DRUG RESISTANCE REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VIVO
LAUDANOSINE
WEAK ACTIVITY
24Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
LAETANINE
None
25Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
LINDCARPINE
None
26Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
PREDICENTRINE,NOR:
None
27Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
CORYDINE,ISO-NOR:
None
28Not specified
ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA
OCOBOTRINE
None
29Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LAUROTETANINE,N-METHYL:
None
30Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PALLIDINE,(-):
None
Show SPARQL Queries (1)